AcquisitionOther
Shin Nippon Biomedical Laboratories, Ltd acquired Satsuma Pharmaceuticals, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Shin Nippon Biomedical Laboratories, Ltd -> Satsuma Pharmaceuticals, Inc. · $0.91
SNBL to Acquire Satsuma Pharmaceuticals Transaction delivers immediate value and liquidity to Satsuma stockholders SNBL to acquire all outstanding shares of Satsuma for upfront cash consideration of $0.91 per share Satsuma stockholders to also receive non-trad
Open source record (SEC) ↗